相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy
Manlio Tolomeo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Silmitasertib (CX-4945) in combination with gemcitabine and cisplatin as first-line treatment for patients with locally advanced or metastatic cholangiocarcinoma: A phase Ib/II study.
Mitesh J. Borad et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both?
Kelly Feral et al.
BIOMOLECULES (2021)
Targeting MCL-1 in cancer: current status and perspectives
Haolan Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
The Immune Regulatory Role of Protein Kinase CK2 and Its Implications for Treatment of Cancer
Huixian Hong et al.
BIOMEDICINES (2021)
Cholangiocarcinoma
Samantha Sarcognato et al.
PATHOLOGICA (2021)
Anti-survival and pro-apoptotic effects of meridianin C derivatives on MV4-11 human acute myeloid leukemia cells
Hyorim Cho et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
The potential and controversy of targeting STAT family members in cancer
Yannick Verhoeven et al.
SEMINARS IN CANCER BIOLOGY (2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Eukaryotic translation initiation factors as promising targets in cancer therapy
Peiqi Hao et al.
CELL COMMUNICATION AND SIGNALING (2020)
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells
Giovanni Di Maira et al.
ONCOGENESIS (2019)
Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinom
Kais Zakharia et al.
TRANSLATIONAL ONCOLOGY (2019)
Role of eIF2α Kinases in Translational Control and Adaptation to Cellular Stress
Ronald C. Wek
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Targeting BCL-2 regulated apoptosis in cancer
Kirsteen J. Campbell et al.
OPEN BIOLOGY (2018)
Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer
Hyun Myong Kim et al.
ANTICANCER RESEARCH (2018)
BCL-2 family proteins: changing partners in the dance towards death
Justin Kale et al.
CELL DEATH AND DIFFERENTIATION (2018)
Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia
L. Quotti Tubi et al.
LEUKEMIA (2017)
Autophagy Induced by CX-4945, a Casein Kinase 2 Inhibitor, Enhances Apoptosis in Pancreatic Cancer Cell Lines
Dae Wook Hwang et al.
PANCREAS (2017)
Sex-specific and race/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the USA: An updated analysis of the 2000-2011 Surveillance, Epidemiology and End Results registry
Sasan Mosadeghi et al.
HEPATOLOGY RESEARCH (2016)
ROLE OF THE PROTEIN KINASE CK2 IN THE BIOLOGY OF CHOLANGIOCARCINOMA CELLS
G. Di Maira et al.
DIGESTIVE AND LIVER DISEASE (2016)
Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells
Hasaya Dokduang et al.
ONCOLOGY REPORTS (2016)
Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPε and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma
Chulwon Kim et al.
BMC NEPHROLOGY (2016)
The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
S. J. Thomas et al.
BRITISH JOURNAL OF CANCER (2015)
Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies
Agnieszka Zimna et al.
BIOMED RESEARCH INTERNATIONAL (2015)
High Expression of HIF-1α, BNIP3 and PI3KC3: Hypoxia-Induced Autophagy Predicts Cholangiocarcinoma Survival and Metastasis
Suyanee Thongchot et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
ER stress signaling in ARPE-19 cells after inhibition of protein kinase CK2 by CX-4945
Johanna Intemann et al.
CELLULAR SIGNALLING (2014)
HIF-1 Signaling in Drug Resistance to Chemotherapy
N. A. Warfel et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia
L. R. Martins et al.
LEUKEMIA (2014)
Overexpressions of CK2 beta and XIAP are Associated with Poor Prognosis of Patients with Cholangiocarcinoma
Fan Zhou et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
Inhibition of protein kinase II (CK2) prevents induced signal transducer and activator of transcription (STAT) 1/3 and constitutive STAT3 activation
Samadhi Aparicio-Siegmund et al.
ONCOTARGET (2014)
Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells
G. Kenneth Gray et al.
ONCOTARGET (2014)
Hypoxia Inducible Factor Expression in Intrahepatic Cholangiocarcinoma
Yuji Morine et al.
HEPATO-GASTROENTEROLOGY (2011)
Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer
Fabrice Pierre et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Emergence of protein kinase CK2 as a key target in cancer therapy
Janeen H. Trembley et al.
BIOFACTORS (2010)
Multi-disciplinary treatment for cholangiocellular carcinoma
Mitsugi Shimoda et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Role of protein kinase CK2 in the regulation of tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis in prostate cancer cells
GX Wang et al.
CANCER RESEARCH (2006)
Surgical management of hilar cholangiocarcinoma
AW Hemming et al.
ANNALS OF SURGERY (2005)
One-thousand-and-one substrates of protein kinase CK2?
F Meggio et al.
FASEB JOURNAL (2003)
分享论文
